CME Group Inc. $CME Holdings Lifted by Promethium Advisors LLC

Key Points

• Promethium Advisors LLC increased its holdings in CME Group by 22.3%, owning a total of 14,975 shares valued at approximately $3.97 million.
• Several institutional investors have significantly raised their stakes in CME Group, with GQG Partners increasing their holdings by 7,676.3% to over 2.2 million shares valued at around $585 million.
• CME Group has announced a quarterly dividend of $1.25 per share, equivalent to an annualized dividend of $5.00 and a yield of 1.9%.

Promethium Advisors LLC increased its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 22.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,975 shares of the financial services provider's stock after purchasing an additional 2,726 shares during the period. CME Group accounts for 2.5% of Promethium Advisors LLC's portfolio, making the stock its 6th largest position. Promethium Advisors LLC's holdings in CME Group were worth $3,973,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in the stock. SeaCrest Wealth Management LLC lifted its holdings in shares of CME Group by 3.0% in the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock worth $366,000 after purchasing an additional 40 shares during the last quarter. OneAscent Financial Services LLC raised its stake in CME Group by 4.0% during the 1st quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider's stock valued at $293,000 after acquiring an additional 43 shares in the last quarter. Ballentine Partners LLC raised its stake in CME Group by 0.8% during the 1st quarter. Ballentine Partners LLC now owns 5,828 shares of the financial services provider's stock valued at $1,546,000 after acquiring an additional 45 shares in the last quarter. Wealthcare Advisory Partners LLC raised its stake in CME Group by 3.6% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock valued at $356,000 after acquiring an additional 47 shares in the last quarter. Finally, Koshinski Asset Management Inc. raised its stake in CME Group by 1.4% during the 1st quarter. Koshinski Asset Management Inc. now owns 3,522 shares of the financial services provider's stock valued at $934,000 after acquiring an additional 48 shares in the last quarter. Institutional investors own 87.75% of the company's stock.

Insider Transactions at CME Group

In related news, Director William R. Shepard bought 256 shares of the business's stock in a transaction dated Wednesday, June 25th. The shares were bought at an average cost of $270.53 per share, with a total value of $69,255.68. Following the completion of the transaction, the director directly owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Charles P. Carey sold 500 shares of the business's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the sale, the director directly owned 4,900 shares in the company, valued at $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

CME Group Trading Down 2.1%

Shares of CME Group stock traded down $5.49 on Friday, reaching $261.94. 1,633,679 shares of the company were exchanged, compared to its average volume of 1,882,480. The stock has a fifty day moving average price of $274.96 and a 200-day moving average price of $269.86. The firm has a market capitalization of $94.40 billion, a price-to-earnings ratio of 25.36, a price-to-earnings-growth ratio of 4.84 and a beta of 0.43. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a fifty-two week low of $212.38 and a fifty-two week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.CME Group's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.56 earnings per share. On average, analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group's payout ratio is 48.40%.

Analyst Ratings Changes

Several analysts have weighed in on the company. Wall Street Zen downgraded CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Oppenheimer lifted their target price on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. UBS Group reaffirmed a "neutral" rating and set a $305.00 target price on shares of CME Group in a research note on Thursday, July 24th. Piper Sandler lifted their target price on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Finally, Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Four research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $261.93.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.